Industry: Clinical Trial Services
Investment Date: October 2018
QHP partnered with the management team to execute a buy and build strategy transforming Catalyst Clinical Research into a full-service, technology-enabled, oncology-focused CRO with a diversified customer base and global reach
Added comprehensive management system to company, introduced a vast pool of connections and channel partners, as well as added additional expertise to the board.
Expanded global operations and increased service offerings
Improved technology-enabled strength for CRO capabilities.